Remote Monitored confirms delay to subsidiary's mask production plans
Remote Monitored Systems updated the market on its wholly-owned subsidiary Pharm 2 Farm (P2F) on Thursday, having previously announced that it was expecting the delivery and installation of the new antiviral mask production line around the end of November.
The AIM-traded firm said it was updated by P2F and the manufacturer of the production line on 25 November, noting that the production machinery was now expected to undergo final acceptance testing in mid-December at the manufacturer's premises in Spain.
“It will then be shipped, installed and commissioned at P2F's Biocity premises in Nottingham,” the board said in its short statement.
“Commercial production and shipment of product is now expected to begin in January.”
At 1259 GMT, shares in Remote Monitored Systems were down 23.22% at 1.96p.